Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma
- PMID: 11182334
- DOI: 10.1016/s0090-4295(00)00905-5
Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma
Abstract
Objectives: In a previous pilot study, a constitutional balanced translocation t(5;20)(p15;q11) was identified in a family with urothelial cell carcinoma (UCC). The purpose of this study was to find (additional) constitutional chromosomal abnormalities in selected families to obtain an indication for genome location(s) of UCC susceptibility gene(s).
Methods: UCC families were selected through an ongoing study on familial clustering of UCC, the largest study on this subject ever performed. This study included 1193 new patients with UCC of the bladder, ureter, and renal pelvis, identified from the population-based cancer registries of the Dutch Comprehensive Cancer Centers East and South. Information on demographic factors, smoking habits, and family history of UCC was collected by postal questionnaires. UCC in the families was verified with pathology reports. Thirty families were selected in which 2 or 3 individuals were affected, preferably diagnosed at a relatively young age. Blood samples were obtained from all probands, and routine cytogenetic analysis was performed on 23 male and 7 female UCC patients. Subsequent spectral karyotyping was performed in 4 patients from families, which were most suggestive for an inherited etiology.
Results: No aberrant chromosomal features were found by either classical or spectral karyotype analyses.
Conclusions: It is conceivable that genetic germline abnormalities do exist in the patients in our study but are below the detection limit of the explorative methods used in this study.
Similar articles
-
The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients.Oncotarget. 2016 May 3;7(18):25826-35. doi: 10.18632/oncotarget.8404. Oncotarget. 2016. PMID: 27029078 Free PMC article.
-
Chromosomes in kidney, ureter, and bladder cancer.Cancer Genet Cytogenet. 1986 Sep;23(1):1-24. doi: 10.1016/0165-4608(86)90145-7. Cancer Genet Cytogenet. 1986. PMID: 3742484
-
Familial aggregation of urothelial cell carcinoma.Int J Cancer. 2002 Mar 10;98(2):274-8. doi: 10.1002/ijc.10191. Int J Cancer. 2002. PMID: 11857419
-
[Primary upper urinary tract tumors and subsequent location in the bladder].Prog Urol. 2009 Oct;19(9):583-8. doi: 10.1016/j.purol.2009.03.007. Epub 2009 May 9. Prog Urol. 2009. PMID: 19800544 Review. French.
-
[Sporadic upper urinary tract urothelial cell carcinomas: identification of interaction between toxic carcinogens and individuals genetic susceptibility].Prog Urol. 2010 Jan;20(1):1-10. doi: 10.1016/j.purol.2009.10.010. Epub 2009 Nov 28. Prog Urol. 2010. PMID: 20123521 Review. French.
Cited by
-
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.Nat Rev Clin Oncol. 2023 May;20(5):287-304. doi: 10.1038/s41571-023-00744-3. Epub 2023 Mar 13. Nat Rev Clin Oncol. 2023. PMID: 36914746 Review.
-
Familial and genetic risk of transitional cell carcinoma of the urinary tract.Urol Oncol. 2008 Sep-Oct;26(5):451-64. doi: 10.1016/j.urolonc.2008.02.016. Epub 2008 Jun 18. Urol Oncol. 2008. PMID: 18562223 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical